YouSaid · the spoken record

Amir Rubin

lines on the record: 41
first: 2020-05-28
most recent: 2020-05-28
sittings or episodes: 1
sources: podcast

Every line below is reproduced as it was said and linked to the record it came from. Nothing here is summarised or generated. Directory · Search · Corrections

“Intercede in between sessions. So we can work on chronic diseases. And then we built our own technology that shows we have about 44% less work in our electronic health record than you'd see in other ones. So the providers are happier. And then finally, we interfaced into the existing ecosystem. We accept insurance, we build digital interfaces to the hospital systems and the specialists so we can help coordinate across a continuum of care. Fundamentally Why healthcare transformation is hard is there's so many stakeholder groups. And what we've done is we've taken a human-centered and technology powered model and tried to address some of the needs of each of the stakeholder groups simultaneously. And that is what's so powerful about our model and why I think we can excel into the future.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Care, but that's frustrating to all the key stakeholders. 50% of family practitioners in the US show symptoms of burnout. They're paid typically compensated on a fee-for-service basis. They get paid for every visit. So what does that economically incentivize? Very short visits and refer everything out to a specialist. Not only does it cost more money, but they're not productive, right? And then physicians are frustrated by the, we call it the burdens of desktop medicine. All this electronic health record and billing and coding and authorizations. And that's not what they got into this for. And then we see the health networks, the health systems, the plans. They're trying to develop these coordinated care networks, but they're frustrated. They're spending a lot of money, but the care isn't more coordinated. So we come in and we say, we transform healthcare for all those stakeholder groups. And now we're showing we could take out costs. So really changing the healthcare ecosystem for”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“I would say that even before COVID, the current system was not meeting the needs of all of its stakeholders. Spending 18% of GDP in the US on healthcare, many studies show over a third of it is considered waste. We actually underinvest in primary care in healthcare. We spend about, in the U.S., we spend about 5 to 7 percent of the premium dollar on primary care versus about close to 14% in OECD nations. The average wait time to a family practitioner in the US is about 29 days. And the average premium for a family is $20,000. We spend a lot of money. There's a lot of waste, and it's really hard to see anybody. Now, we have excellent providers, excellent hospitals, and for those who can have access, there can be very high quality.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, well, I actually, maybe why I feel like I'm managing it well is I've used the one medical program. So we have a great program called Shift, which is a group visit session. And now it's virtual. So you could do it online. I also recommend putting a half an hour of a Seinfeld rerun too. That works for me too, just to keep it light as well.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“A lot being thrown at people when people are dealing with a lot of stress and anxiety. So we recognize that. We recognize it in our employers and their employee bases. We have to recognize it in our own team members, right? We have physicians there on the front lines putting PPE in the early stage of this thing. Yeah, that's scary. I think also, frankly, it's why I like getting into things when you get into it. It's like if you think back to your school days, right? Like you were stressed and anxious when you didn't, when you were not studying and waiting till the low last minute. Once you jumped into it, you're in it, right? Like, so I like to get in it and I don't have time to think about anything else. I'm just in it. Like I got to do these things and I enjoy doing those things, but we do have to recognize what's going on for our society, our world, really, and be cognizant of that.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Gives me great anxiety. I have friends who have been sick, I know people who have died. I have many colleagues and friends who have lost their jobs. That is very stressful. Seeing that suffering, that is tough. And we're seeing it in our membership base. And we're seeing it in society. We're seeing the rise hundreds of percent increase in our diagnosis across our members of anxiety and depression. Not surprising, right? So we've also expanded our services as a result there. We call it mindset by one medical. We've always had actually these group sessions or group visits that use cognitive behavioral therapy and coaching techniques. Now we have those virtually and we have virtual coaches and we have therapists. And we're seeing a rise in that need. Look, there's”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Probably the short answer is no. I like to say I have a lot to do with the very short amount of time and a whole heck of a lot is writing on it. But there's no stress. But, you know, I feel very, very fortunate to work in an incredible organization with an incredible team that has a mission that's to transform healthcare. And at the crux, we want to be human-centered and technology powered. And I see an amazing window of opportunity here, A, as a company, not just in this COVID time. We're post-IPO, we're growing. Like this is an opportunity to be transformative in healthcare and to be transformative in people's lives. I think that's super exciting. And to me, it's very energizing. This is a stressful time for a lot of people because there's some terrible things going on. People are getting sick. People are dying. People are losing their jobs.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“How would we make this work easier for our team members? What would you need to do to make them feel more comfortable during this time, to build up their confidence? How's it working? Those are the things that we learn by kind of going and seeing.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Our own clinics and testing sites are like, hey, we have some more capacity. They're the amazing heroes. My putting on a mask and coming saying, hi is irrelevant. So I have been tested. But part of what I wanted to see when we rolled out the app how the result came in, what it looked like, what the experience was. I wanted to go do it myself. I wanted to get the in-clinic experience. And it's not like I'm secret shopping. We do this all the time. This is what we're doing in our process improvement. It's not like I know what the magical answer is, but you get more perspective on it. You're like, oh, okay, that worked pretty well. You know, I would tweak this thing. And, you know, I try not to be the annoying CEO who says, well, what about these five features, right? But it's not just me when the whole company is doing that. You have much greater insight into the experience. We want to get close to the experience, close to the process, close to the team who's doing the work.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, so I'd say the first thing is I'm not doing anything special. I would say much of what I've been doing is remote. And during this later times, I've made some visits. But this is less about me and what I'm doing. It's really how do we run our company? And we want to be a company that we're connected to each other, that we're connected to our members. We're connected to our clients. And you can do it through Zoom. You could do it through in person. We're seeing COVID patients. I mean, and that's what we do. So we need to do that thoughtfully and not mix inappropriate people. And we've done very thoughtfully. But I'd say the broader point is how do we keep our ear to the ground of what's going on with our amazing team members who are out there on the front line? We also have our physicians in New York City who have volunteered in the hospital wars and in the ERs because in addition”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Usually, the future states are a little more predictable. But in a high growth, if you will, startup or early IPO mentality, we got to move fast. We got to respond quickly. So this is, again, the kind of way we should be responding every day. And frankly, maybe that's even some of the fun lessons for this from us. Like, oh, we could move even faster.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“In a day or two, we've got the new approach or how we're going to disinfect in an office or how we're going to run a respiratory care clinic or how a person who works at the front desk is going to don and doff PPE, right? How do you get thousands of people trained in that quickly? Well, you can't, not easily, unless you have an operating system because we're able to roll that out in a standard way nationally quickly. That also prepares us to adapt quickly. So one is we think about scenarios for the future, but then two, we build a framework and it's the same on our technology stack. You know, it's built in a modern way with modern APIs and working with agile teams. We reposition some of those teams. And it's really not that different from how we work every day. Yeah, we don't have pandemics every day. And so.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“We have to hard code it, we have to train, we have to onboard, we have to everyday go to the field and observe. I do put my mask on and go to our clinics and observe, but we do a lot of Zoom observations as well. And because we have that approach, we can stand up sometimes overnight. We talked about today on testing, right? Like, that's all evolving every day. When we go out to our thousands of team members,”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“How would the physical location need to adapt? Gosh, if in this country we need to vaccinate 350 million people, maybe we're opening the parking lots again, right? So we have what we call strategic alignment and deployment. So how do we across all of our departments have some alignment on what these future states might be? And how do we have cross-functional teams planning of that? Then how do we do improvement and innovation work? Think about that as lean and agile and design thinking kind of approaches and how do we think about always from the user perspective on out, we kind of put the member at the center of everything we do. And then the third area we call active daily management. It's great to have a strategy and goal or a perspective on the future. It's even fun to have some improvement teams. But what do we do each and every day always that you can execute at scale at 90th percentile plus performance, we have to develop standard”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“So, a few things. One, we're always looking towards what's next. Right as we were in the first few weeks of this, as we were working on how do we get PPE and how do we stood this up, we were also thinking about how are we going to get people returned to work. And then we were thinking about, well, hopefully there'll be an antiviral and then eventually there'll be a vaccine. So we're thinking about all of those phases. And partly not because we're such great prognosticators. That's actually how most diseases work, right? Like there is Tama flu and there is a flu vaccine, right? And we do administer those things and people do get them. And there are analogs in other conditions. We hope those come soon and we don't know exactly when these things are going to come. But those are not unreasonable future states to think about. And how would we be prepared? How would our tech platform need to adapt?”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Our model is well positioned because it is multimodal. It's not just digital. It's not just inbound responsive virtual. It's outbound proactive digital health. It's not just virtual video. It's messaging. It's text. It's apparently not just an office but can be in parking lots, right? And because the people are flexible and the tech was flexible. That was all within our DNA kind of coming into this.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Well, I don't know if that was just a riff, Bob, but we just had a press release two days ago with montage hotels, and that's what we're doing. We're offering this to their guests because during this time for travelers, is safety and health high of mind? Yes. So that is actually something we are doing. And we just had our earnings call last week. We were growing nicely in the first quarter. I call that BCE. That's before the COVID era and also in CE in the COVID era, right? And so now there's also just these further proof points. Also during this time, we had a paper published in JAMA Network Open, the Journal of American Medical Association, that showed that our model took out 45% of the health benefits costs. 45% of the health benefits costs for an employer account. So, you know, that's another proof point. It's kind of just building on kind of the core of what it is we do.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Want to do and who we are? Yes, we did have to roll out new features. We did have to recode things under software. Like how do you schedule in a parking lot? Which room do you book them into? You know, parking slot 97? Like, how are we going to do that? So all of that we had to do on the fly, but we had kind of this operating system, this framework of how we work. We had a culture, we had a mission that all of that was very aligned to. So that maybe shrunk the gap of the change that it might have felt like to the organization.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, I would characterize it as further features and proof points on our core model. So our model Membership based, relationship based. We always had enterprise relationships. We always met with those enterprise leaders. We were typically talking about breast cancer awareness month or mental health awareness month, and we would roll out initiatives for that, or we would do in-app screening, or we do outbound population health, or certain areas of focus. We added pediatrics, we've added more virtual behavioral health. Now we had to add locations in parking lots. Okay, we didn't think about that. That was new, but we always did testing. We always had locations. We always engaged with employers. So I think this is partly what's allowed us to move so quickly and serve kind of at scale during this time. And at some level, I'd say not only not miss a beat, but probably in its own twisted way, get energized by this and be able to move faster because this is consistent with what we.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Confident and comfortable and manage their anxiety and stress during this. And these are the kind of things we're working with on employers.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“So this program we call it Healthy Together is just that. So we're working with employers on their programs. And it's this screening approach. It's this testing. It's thinking about cohorts and how to bring people back. And look, many organizations are self-included, have been running the whole time. We were out there doing testing. We had to do PPE. So, you know, and there's others who are in manufacturing. Employers have gotten up the learning curve. Societies is moving up the learning curve. And so we're having really great discussions, you know, with banks, with technology companies, with manufacturing companies, with professional services companies. How do you mitigate and manage risk? But keep your mission alive and keep doing what you're doing and address your community. And ultimately your employee base, right? How do you keep them?”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Yes, they are. Thankfully, we have incredible medical leaders' epidemiologists, public health experts. I'm just the parakeet here repeating what I've learned from my experts. Now, I do have a degree in public health myself, but we actually have experts on this. Those people came out and they're like,”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“These are getting to closer, right? You're probably not going to have continuous testing, but we can do a lot to mitigate the risk.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Yes, you know, I will say, actually, pure temperature alone isn't very correlated because the asymptomatics don't have temperature. So it's the combination of all the questions is really what it is. Having the thermal gun at the door will miss most everybody because they're asymptomatic. And by the way, they're already at the front door at work. Maybe they should have taken the temperature at home is kind of what we would recommend, right? The reality is we won't end up testing everybody every day before and after their commute. So you'll never be perfectly assured. So in the meantime, you want to do other risk mitigating things. So you're still going to want to rely on kind of screening questions. You're going to still want to be smart about that. You're still going to want to rely on some social distancing. You're still going to want to rely on probably masks or double masking, right? Each of us wears a mask. And it's the combination of all of these things that is risk mitigating. There is no perfect test, even though someone...”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“And so we want to be vigilant. We want to be screening. So we've built this into our app so an employer can roll this out, an employee can fill it out on a daily basis. They can also push a button and get their tests and they can get their test results. And if they're positive, they can talk to a provider, right? So we have the full suite. But on the back end, we can do reporting to the employer. Here's your 5,000 employees. And here's how they're risk assessed today. These 4,900 said no symptoms. And 100 said symptoms were somewhere in between. So testing or screening, you know, is relevant in acute diagnosis, but also in how do we want to surveil a population over time.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Any symptoms? Anybody in your house have any symptoms? Have you traveled? Have you been exposed? Anybody in your house been exposed? And so by asking these questions on a routine basis, and do you have a temperature? We've actually run some machine learning models so far. And these are looking highly, highly correlated with PCR positive testing.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“That was right, except let's talk about the screening a little bit more. The antibodies in the immunity are the fun thing that everybody wants to know from the individual perspective, but not actually if we want to keep in the short term the work side clear, we actually want to know if somebody is currently infectious, right? Now we want to go back to work, back to school. Now, I like to say it's not really back to work. Many people are working, it's, but back to work site, right? Work site reentry. So we have a program we call it One Medical Healthy Together. And so this is really about ongoing screening. And so sure, it could be about testing. But are we really going to test every person every day before and after their commute may not be practical? So at a minimum, we could screen every person every day by asking them questions.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Plus IGM. Now there is some funky things when we're seeing in the results. And the testing is evolving. But conceptually, that would kind of give you a window into the, call it the first seven to ten days. It is then now the IGG antibodies that everybody's excited about, like did I have it and does that confer immunity, we don't know really if it confers immunity and for how long. But I think the hope is at least you will have some built up tolerance antibodies to the condition. I still think the running hypothesis.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“You might ultimately, or said slightly differently, you might have greater confidence in a result based on the sensitivity and specificity and the prevalence rate in the community. Now, the body generates antibodies in fighting off infections. And there are some antibodies that come earlier on when it's fighting a virus and there's some that come later on. All this immunity talk is the antibodies that come later on. the IGG that you might have heard about the immunoglobulin G. Then there is the IgM, which is usually produced sooner in the condition. So there is in theory the PCR would pick up the condition in an earlier time frame, but if it's too early, it might miss it. So there could be logic in the acute phase to running PCR.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“You have some of these tests that actually have 100% specificity, 99% specificity. That'll tell you something else. Now, in New York City, where you might have 15 to 20% prevalence in a community, a slightly lower sensitivity and specificity may give you a better result. So one, understanding first, what test you need. By and large, it was the PCR for diagnosing acute, understanding who we're sending it to, what's their sensitivity and specificity, what platform is it on. And there's a lot of trade-offs here. There's some tests that turn results quicker, but they have lower sensitivity and specificity.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Because even something at a 90% sensitivity or specificity, which sounds pretty high, but if there's kind of a little bit of epidemiology here, if there's very little prevalence in a community, say in my community in the Bay Area, it looks like maybe there's 5%. A test that's 90% sensitive and specific will only have maybe a 50% positive predictive power.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“I think we need to think about Testing or more broadly screening in terms of what are we trying to accomplish at one level, sometimes we want to test and screen and assess if somebody has COVID. And then there's a separate question of how do we want to screen a population on an ongoing basis. Both are important and we need to do both. In an acute diagnosis, the PCR testing is really at the crux of the diagnosis. One of the important things on any of these tests is making sure the test is sensitive and specific, right? You want to capture the actual positives and you don't want to miss any positives, right? And early on, we were actually having many, many calls with the chief technology or chief quality or chief scientific officers at the last.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Demand. So while there was a great influx, it wasn't unexpected. And our members were so grateful, you know, and part of, I think, healthcare is certainly you want to help people medically when they have acute conditions or help them with chronic conditions to change. But often it's about alleviation of anxiety. It's uncertainty. How's my child? Are they going to be okay? Like there's nothing, there's no worse feeling and there's nothing scarier. So in two or three minutes, somebody's talking to you and maybe having a video chat and maybe listening to your child, right? Like, oh my gosh. And like, no, it doesn't sound like COVID. We have a tight bond with our members. We have 90 plus percent retention on our direct-to-consumer and our B2B and our enterprise clients. So they stay with us. We know them. They were very grateful in general during this time of COVID.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Yes, they responded as we thought they would, and we were surprised by some things. I think our model makes access very frictionless. So you can get on the app and we bundle all the on-demand digital health into the membership. So we're not charging a copay or deductible or billing. So in normal times, our members engage with us about seven times a year. And we have a 47% monthly active use rate. So people are on our tech like every other month. So in the first few weeks of March, oh, yes, people reached out in extraordinary levels because we don't put barriers to them reaching out. Now, to help ourselves and to still perform at that amazing service level, we said, okay, well, how about having this COVID questionnaire? We're going to ask you these questions anyhow. How about filling that online? How about we'll call you? Like we did things to manage the immediate surgeon.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Out to you, and boy, then you want maybe a test. Let's schedule you. You don't have to go stand in a line. You need to be seen in person. We took some of our offices and we transformed them into what we called respiratory care clinics. So the staff looked like the staff in emergency rooms. We're in full PPE, all the precautions. And then we had other offices that were like for the non-COVID symptomatic patients. Even within the digital arena or even within the physical arena, we did more kind of segmentation. And then we also said, well, if you can't come in to see your provider, you can book a scheduled virtual visit with your provider.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“It is right, Bob. So you're one medical. We're going to look after you. You want to text me. You want to message me. You want to call me. You want a video. You want to see me in person during this time. You want to see me in a parking lot and I'll stick a Q-tip up your nose. Any of those are fine. Moreover, since we know who all our members are, because they're signed up as members, we'll reach out to you, which we did. Concerned about COVID, anybody in your house, anybody have symptoms? And so our approach is this longitudinal relationship with people. And certainly different modalities of how we serve people were impacted differently. So even on our digital health, for example, we always had kind of a structured questionnaire approach and you can kind of have a structured conversation. Or you could always just message a provider or you could do a video chat. Well, during this time, we stood up kind of a structured questionnaire around COVID. Here are the symptoms. Fill this out and we'll reach.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Coming into the office, let's go just do this in the community. And then we started connecting up with people in different markets. We've also done this for lyft drivers. We've done it for any healthcare worker. We just said we'll open up. And then I think the city governments were like, hey, who are these folks? Can they help us?”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“We're a leading medical provider in New York City, in San Francisco. We serve 7,000 companies. We serve some well-known companies like Google or SpaceX. And frankly, we serve a lot of people, including who work in government, who signed up as individuals. And because we have a national model, the one medical performance system or TOPS, how we standardize operations at scale, we were prepared early on to serve. We had interfaces with labs. We had specimen vials. Unlike most doctors' offices, we always did phlebotomy. We always did specimen collection. We had a national approach on PPE. We had to build like everybody else a national supply chain. We did a lot of running to Home Depot to get painters' suits early on. We did some improvisation. And we have a really strong service oriented culture and are people like, hey, if people aren't”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“We saw impacts in two different ways. So, as you mentioned in the introduction, where this membership based primary care platform that combines digital health and in-person care and testing. So who knew you'd want digital health and testing during these times, right? So at some level on the digital health and testing front, we saw increases there. And then as we went to shelter in place in a lot of communities, we saw reductions in in-person care. You can see differences across markets. Just in our early weeks, we were seeing positive rates in our tests of 15, 20 plus percent in New York City. And we're seeing 3% in Phoenix. So it was pretty clear to us early on that this is going to be significant, but also maybe different across the United States in different cities.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“It takes a lot of energy and effort to get to the IPO line. We were shooting for the end of January. So here we are. It's January 31st. And three pieces of news come out around that day. But first piece of news is there's this weird virus in China that might impact the supply chain. Second piece of news is looks like Brexit's happening. And the third piece of news is the president was just impeached. So I was like, oh, this would be a good day to do an IPO. So actually on our IPO day, really the market was really, it seems to me that was most spooked about actually what we now know as COVID-19. Ironically, the other two things weren't really moving the market or so the pundits were saying. So we pretty much knew from then that this was going to be an impact.”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT
“Pretty clear to us early on that this is going to be significant, but also maybe different across the United States. Want to text me? You want to message me, you want to call me, you want a video, you want to see me in person during this time. You want to see me in a parking lot and I'll stick a Q-tip up your nose. Any of those are fine. Because we have our approach of how we standardize operations at scale, we were prepared early on to serve. We had a national approach on PPE. We had to build like everybody else a national supply chain. We did some improvisation. It's really not that different from how we work every day. We don't have pandemics every day. And so, you know, in a high-growth startup, we got to move fast. We got to respond quickly”
2020-05-28 · Masters of Scale · Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin · IDENTIFIED FROM THE TRANSCRIPT